Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study (Q57262599)
article
Language:
Current Data About Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study
(P31) (Q13442814)

(P50) (Q85737948)
(P1545) 13
(P1932) Garrett M. Brodeur

(Q88386694)
(P1545) 12
(P1932) Robert C. Seeger

(Q91544711)
(P1545) 11
(P1932) Katherine K. Matthay

(Q90622519)
(P1545) 1
(P1932) John M. Maris

(P304) 1888-1899

(P407) (Q1860)

(P433) 9

(P478) 18

(P577) Tuesday, May 9, 2000

(P921) (Q181600)

(Q938205)
(P887)

(Q124059385)
(P887)

(P1433) (Q400292)

(P1476) "Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study" (language: en)

(P2093) Matthew J. Weiss
(P1545) 2

Chun Guo
(P1545) 3

Robert B. Gerbing
(P1545) 4

Daniel O. Stram
(P1545) 5

Peter S. White
(P1545) 6

Michael D. Hogarty
(P1545) 7

Erik P. Sulman
(P1545) 8

Patricia M. Thompson
(P1545) 9

John N. Lukens
(P1545) 10

other details
aliases Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study
description article

External Links
(P356) 10.1200/JCO.2000.18.9.1888
(P698) 10784629